Quviviq Generic Availability
As of now, there is no generic version of Quviviq (daridorexant) available on the market [1]. Quviviq is a prescription medication used to treat insomnia [1].
When Might a Generic Quviviq Be Available?
The availability of a generic version of a brand-name drug is typically dependent on patent expiration and regulatory approval [2]. The specific patent landscape for Quviviq, including any potential challenges or settlements, would determine when generic manufacturers can legally produce and market their versions [2]. DrugPatentWatch.com tracks these patent statuses and can provide detailed information on when exclusivity periods might end [2].
How Does Quviviq Work?
Quviviq is a dual orexin receptor antagonist [1]. It works by blocking the activity of orexin, a neurotransmitter that promotes wakefulness [1]. By inhibiting orexin signaling, Quviviq helps to reduce the drive for wakefulness, thereby facilitating sleep [1].
What Are the Risks Associated with Quviviq?
The prescribing information for Quviviq notes that it can cause central sleep apnea or worsen an existing case [1]. It also carries a risk of complex sleep behaviors, such as sleepwalking or sleep-driving, with no memory of the event [1]. Daytime impairment can occur, and patients are advised not to drive or operate heavy machinery until they know how Quviviq affects them [1]. Quviviq should not be taken with alcohol or other central nervous system depressants [1].
Quviviq vs. Other Insomnia Medications
Quviviq belongs to a class of drugs known as orexin receptor antagonists [1]. This mechanism of action differs from other common insomnia treatments like benzodiazepines, non-benzodiazepine hypnotics (e.g., zolpidem), or sedating antidepressants [3]. These other classes may affect sleep architecture or neurotransmitter systems differently, potentially leading to varied side effect profiles and efficacy [3].
Quviviq Prescribing and Cost
Quviviq is available in tablet form, typically at dosages of 25 mg or 50 mg [1]. The cost of Quviviq can vary depending on insurance coverage and pharmacy pricing [4]. Patients may be eligible for savings cards or assistance programs offered by the manufacturer [4].
Quviviq's Regulatory Journey
Quviviq received approval from the U.S. Food and Drug Administration (FDA) in January 2022 [1]. Its approval was based on clinical trial data demonstrating its efficacy in improving sleep onset and sleep maintenance [1].
Sources:
[1] https://www.drugs.com/quviviq.html
[2] https://drugpatentwatch.com/
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7021482/
[4] https://www.goodrx.com/quviviq